Ownership history in Kynam Capital Management, LP · 17 quarters on record
This page tracks every 13F SEC filing in which Kynam Capital Management, LP reported a position in VIRIDIAN THERAPEUTICS INC (VRDN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 1,470,541 | -2,957,386 | -66.8% | 2.92% | $45.8M | $31.12 |
| 2025 Q3 | UNCHANGED | 4,427,927 | — | 0% | 7.11% | $95.6M | $21.58 |
| 2025 Q2 | REDUCED | 4,427,927 | -272,073 | -5.8% | 6.66% | $61.9M | $13.98 |
| 2025 Q1 | ADDED | 4,700,000 | +1,373,738 | +41.3% | 5.32% | $63.4M | $13.48 |
| 2024 Q4 | ADDED | 3,326,262 | +814,967 | +32.5% | 3.77% | $63.8M | $19.17 |
| 2024 Q3 | ADDED | 2,511,295 | +761,295 | +43.5% | 4.38% | $57.1M | $22.75 |
| 2024 Q2 | ADDED | 1,750,000 | +1,616,123 | +1207.2% | 1.76% | $22.8M | $13.01 |
| 2024 Q1 | REDUCED | 133,877 | -474,038 | -78.0% | 0.25% | $2.3M | $17.51 |
| 2023 Q4 | REDUCED | 607,915 | -91,766 | -13.1% | 1.47% | $13.2M | $21.78 |
| 2023 Q3 | REDUCED | 699,681 | -9,817 | -1.4% | 1.76% | $10.7M | $15.34 |
As of 2025 Q4 — sorted by position size